Prostate Cancer (PCa) / PSA Test

Prostate Cancer

People of Color are more likely to get advanced prostate cancer.

Patients of Color are less likely to get PSA screenings, a blood test that can signal whether you have prostate cancer, leading to more people from our communities being diagnosed with advanced prostate cancer.

African American and Hispanic American men also have less access to prostate cancer treatment and experience longer delays between diagnosis and treatment. These delays in screenings and between diagnosis and treatment lead to worse survival rates.

When we share our health care journey, we can inspire someone who looks like us to take action, which may improve their outcomes.

Underrepresented communities are at greater risk.

When more people share their story, more power goes into the hands of patients.

“…after my prostate cancer surgery, I learned two men in my family had been diagnosed.

Family history is critical for doctors and impacts their decisions — including when to start screenings, especially because in Black men prostate cancer may start earlier and have no symptoms until it is advanced.”

—Mical, Prostate Cancer Survivor

Mical, Prostate Cancer Survivor
and CHM Community Activator

Interested in sharing your story? If you are selected, you will be paid for your time.

African American Community

African American men are more than 1.5 times more likely to develop prostate cancer than White men.

Compared to non-Hispanic White men, African American men are nearly 2.5 times more likely to die from prostate cancer.

Outcomes are worse for African American men because they are less likely to be screened or to receive treatment for prostate cancer.

Asian American Community

Hispanic American Community

What is the PSA test?

Prostate-specific antigen, or PSA, is a protein produced by the prostate. The PSA test is a blood test that measures the level of PSA in the blood. The level of PSA is often higher in people with prostate cancer.

The PSA test was initially approved by the FDA in 1986 to monitor a man’s prostate cancer after they were diagnosed.

Laurean, Certified Physician Assistant

The importance of regular PSA screenings

In 1994, the FDA approved the PSA test to be used to aid in diagnosing prostate cancer in men 50 years of age and older. It is recommended to begin PSA screening earlier than 50 in specific populations that are at higher risk for prostate cancer.

The American Urology Association recommends PSA testing starting at age 40 for African American men due to their higher risk of getting prostate cancer.

Please speak to your doctor about getting a PSA screening, even if you do not have any symptoms.

Men can have prostate cancer without experiencing any symptoms. Getting regular screenings can help identify and diagnose prostate cancer earlier, which can increase your chances of successful treatment.

What if you have been diagnosed with prostate cancer?

First, don’t lose hope. There are many FDA-approved treatment options, even to treat more advanced prostate cancer. Work with your doctor and consult with an oncologist, a specialist who identifies and treats cancers.

Have you considered joining a clinical trial?
If you are interested in joining a clinical trial or if you want to learn more—Let’s get connected. We can help you identify a clinical trial that is the best fit for you.

Interested in sharing your story?
We want to hear from you. We must raise our voices to ensure that health care works for all of us. If you are selected, you will be paid for your time.

Connect With Us

Are you interested in sharing your story to educate others?
Fill out the form below to schedule a time to chat.
If you are selected to share your story, you will be paid for your time.

We take your privacy seriously.